Gyros Protein Technologies

Recorded Webinar from March 22, 2018

Critical reagent characterization on Gyrolab® using solution based affinity module: a case study


Other than specificity, the affinity (KD) of an antibody reagent binding to a drug target is the most important property that drives PK, ADA and NAb assay performance. Kinetic properties (Kon and Koff) may be determined to calculate KD using surface-based methods, such as Biacore or Octet. Alternatively, equilibrium-based methods may be utilized by determining concentrations of binding partners in solution. Gyrolab was evaluated as a tool to measure equilibrium solution-based KD of critical reagents (Fab and mouse Mab) binding to various human Mab drug targets and the data compared to kinetic-based surface methodologies, such as Octet and Biacore. In addition, Gyrolab affinity assay data was evaluated using KinExa software to compare and establish a global fit for a more accurate KD measurement. Differences in affinity measurements were found across methodologies and can be attributed to a variety of factors, including avidity, valency of interactants, assay format and matrix effects. Gyrolab is a useful tool to characterize high affinity assay reagents that are beyond the detection limits for Octet or Biacore, and affords automation, short assay/contact time, small reagent volumes and unmodified interactants.

  • Gyrolab solution-based method for measuring KD values in the low pM range
  • Feasibility of Gyrolab to characterize reagent affinity to Mab drug and comparison to alternate methods (Biacore and Octet)
  • Data fit comparison between KinExa and Gyrolab software
  • Case study: high affinity interaction between 2 Mabs (Low pM KD Range)

Alison Joyce 
Senior Principal Scientist

Biomedicine Design, Discovery Bioanalytical and Critical Reagent Group
Pfizer Inc.

If you have problems viewing the webinar, please contact